Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Cash from Financing Activities (2019 - 2026)

Biodesix filings provide 8 years of Cash from Financing Activities readings, the most recent being $16.9 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 17319.59% to $16.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $33.2 million, a 35.32% decrease, with the full-year FY2025 number at $16.4 million, down 68.46% from a year prior.
  • Cash from Financing Activities hit $16.9 million in Q1 2026 for Biodesix, up from $1.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $51.3 million in Q2 2024 to a low of -$2.8 million in Q1 2022.
  • Median Cash from Financing Activities over the past 5 years was $1.7 million (2025), compared with a mean of $10.2 million.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 671.97% in 2022 and later surged 17319.59% in 2026.
  • Biodesix's Cash from Financing Activities stood at $41.8 million in 2022, then plummeted by 48.08% to $21.7 million in 2023, then plummeted by 100.83% to -$181000.0 in 2024, then skyrocketed by 1044.2% to $1.7 million in 2025, then soared by 888.71% to $16.9 million in 2026.
  • The last three reported values for Cash from Financing Activities were $16.9 million (Q1 2026), $1.7 million (Q4 2025), and $4.8 million (Q3 2025) per Business Quant data.